Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

被引:60
作者
Fu, Tong-Ming [1 ]
Freed, Daniel C. [1 ]
Horton, Melanie S. [1 ]
Fan, Jiang [1 ]
Citron, Michael P. [1 ]
Joyce, Joseph G. [1 ]
Garsky, Victor M. [2 ]
Casimiro, Danilo R. [1 ]
Zhao, Qinjian [3 ]
Shiver, John W. [1 ]
Liang, Xiaoping [1 ]
机构
[1] Merck Res Labs, Dept Vaccine Basic Res, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Med Chem, West Point, PA 19002 USA
[3] Merck Res Labs, Dept Bioproc & Bioanalyt Release, West Point, PA 19002 USA
关键词
Influenza virus; M2; protein; M2 peptide vaccines; Monoclonal antibody; ION-CHANNEL ACTIVITY; INTEGRAL MEMBRANE-PROTEIN; M-2 PROTON CHANNEL; EXTRACELLULAR DOMAIN; MATRIX PROTEIN-2; MICE; VACCINE; REPLICATION; IMMUNITY; IMMUNIZATION;
D O I
10.1016/j.virol.2008.11.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
M2 protein of influenza A virus has been implicated as a target for vaccines with broad cross-strain coverage. Studies in small animal models have shown that antibody responses induced by 23-mer M2 peptide vaccines can provide protection against influenza A virus challenge. To study antiviral mechanisms of Merck M2-OMPC conjugate vaccine, we generated and characterized four M2 peptide-specific monoclonal antibodies (mAbs). Here we demonstrated that the protection by our M2 mAbs is independent of NK-mediated effector functions in mice. The protective mAbs preferentially bind to M2 multimers composed of two or more M2 peptides in parallel orientation. Our findings indicate that the protective M2 Ab prefer to bind to epitopes located within the N-terminal 10 amino acids of the M2 peptide, and the epitopes are likely formed by two M2 peptides in parallel orientation. The implications of these results in antiviral mechanisms of immune responses induced by M2 vaccines are discussed. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:218 / 226
页数:9
相关论文
共 30 条
[1]  
DENKERS EY, 1985, J IMMUNOL, V135, P2183
[2]   Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys [J].
Fan, JA ;
Liang, XP ;
Horton, MS ;
Perry, HC ;
Citron, MP ;
Heidecker, GJ ;
Fu, TM ;
Joyce, J ;
Przysiecki, CT ;
Keller, PM ;
Garsky, VM ;
Ionescu, R ;
Rippeon, Y ;
Shi, L ;
Chastain, MA ;
Condra, JH ;
Davies, ME ;
Liao, J ;
Emini, EA ;
Shiver, JW .
VACCINE, 2004, 22 (23-24) :2993-3003
[3]   Viral ion channels: structure and function [J].
Fischer, WB ;
Sansom, MSP .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1561 (01) :27-45
[4]   Modified M2 proteins produce heterotypic immunity against influenza A virus [J].
Frace, AM ;
Klimov, AI ;
Rowe, T ;
Black, RA ;
Katz, JM .
VACCINE, 1999, 17 (18) :2237-2244
[5]   A SWITCH BETWEEN 2-STRANDED, 3-STRANDED AND 4-STRANDED COILED COILS IN GCN4 LEUCINE-ZIPPER MUTANTS [J].
HARBURY, PB ;
ZHANG, T ;
KIM, PS ;
ALBER, T .
SCIENCE, 1993, 262 (5138) :1401-1407
[6]   INFLUENZA VIRUS-M2 INTEGRAL MEMBRANE-PROTEIN IS A HOMOTETRAMER STABILIZED BY FORMATION OF DISULFIDE BONDS [J].
HOLSINGER, LJ ;
LAMB, RA .
VIROLOGY, 1991, 183 (01) :32-43
[7]   EFFECTS OF ANTIBODY TO THE INFLUENZA-A VIRUS M2 PROTEIN ON M2 SURFACE EXPRESSION AND VIRUS ASSEMBLY [J].
HUGHEY, PG ;
ROBERTS, PC ;
HOLSINGER, LJ ;
ZEBEDEE, SL ;
LAMB, RA ;
COMPANS, RW .
VIROLOGY, 1995, 212 (02) :411-421
[8]   Influenza a vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity [J].
Jegerlehner, A ;
Schmitz, N ;
Storni, T ;
Bachmann, MF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5598-5605
[9]   Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro -: Implications for vaccine design [J].
Joyce, JG ;
Hurni, WM ;
Bogusky, MJ ;
Garsky, VM ;
Liang, XP ;
Citron, MP ;
Danzeisen, RC ;
Miller, MD ;
Shiver, JW ;
Keller, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) :45811-45820
[10]   INFLUENZA VIRUS-M2 PROTEIN IS AN INTEGRAL MEMBRANE-PROTEIN EXPRESSED ON THE INFECTED-CELL SURFACE [J].
LAMB, RA ;
ZEBEDEE, SL ;
RICHARDSON, CD .
CELL, 1985, 40 (03) :627-633